Valuation: Genesis Fertility Center

Market Cap 506M 15.03M 13.18M 12.18M 11.2M 21.14M 1.45B 21.48M 146M 57.1M 709M 56.46M 55.22M 2.44B P/E 2026 *
32.9x
P/E 2027 * 28.8x
Enterprise Value 506M 15.03M 13.18M 12.18M 11.2M 21.14M 1.45B 21.48M 146M 57.1M 709M 56.46M 55.22M 2.44B EV / Sales 2026 *
1.46x
EV / Sales 2027 * 1.38x
Free-Float
17.02%
Yield 2026 *
2.17%
Yield 2027 * 2.17%
05-14 Genesis Fertility Center Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-14 Genesis Fertility Center Public Company Limited Announces Board and Committee Changes CI
02-23 Genesis Fertility Center Public Company Limited Proposes Cash Dividend for the Year Ended 31 December 2025, Payable on 26 May 2026 CI
02-23 Genesis Fertility Center Public Company Limited Announces Changes in Committee Compositions, Effective February 23, 2026 CI
02-23 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
12-17 Genesis Fertility Center Public Company Limited Announces Board and Committee Resignations, Effective December 16, 2025 CI
11-10 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-09-16 Genesis Fertility Center appoints Nathee Tungchitsodsai as CEO RE
25-09-15 Genesis Fertility Center Public Company Limited Announces Appointment of Nathee Tungchitsodsai as Chief Executive Officer, Effective 16 October 2025 CI
25-09-12 90,750,000 Common Shares of Genesis Fertility Center Public Company Limited are subject to a Lock-Up Agreement Ending on 13-SEP-2025. CI
25-08-15 Genesis Fertility Center Public Company Limited Announces Executive Changes CI
25-08-13 Genesis Fertility Center Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-08-12 Genesis Fertility Center Public Company Limited Announces Cash Dividend for the Period from January 1, 2025 to June 30, 2025, Payable on September 10, 2025 CI
Manager TitleAgeSince
Chief Executive Officer - 2025-10-15
Director of Finance/CFO 48 2019-12-31
Chief Operating Officer 43 2016-12-07
Director TitleAgeSince
Director/Board Member 57 2016-12-07
Chairman 57 2016-12-07
Director/Board Member 53 2021-11-15
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 15.18M
+0.13%+3.32%+73.68%+44.68% 137B
-0.20%-8.90%+2.58%+29.20% 82.34B
+3.04%+1.01%+5.16%+62.69% 26.9B
-1.43%+0.11%+24.41%+45.12% 23.32B
+0.61%+0.23%-15.10%-28.90% 19.94B
-0.27%-4.83%+11.04%+141.86% 16.79B
-0.92%-0.31%+7.36%+6.26% 15.38B
-1.21%+0.56%+65.84%+123.46% 15.21B
+0.07%+0.81%-7.99%-13.15% 12.84B
Average -0.05%-1.00%+18.55%+45.69% 38.87B
Weighted average by Cap. +0.20%-1.01%+34.07%+42.53%

Financials

2026 *2027 *
Net sales 346M 10.28M 9.01M 8.33M 7.66M 14.45M 991M 14.69M 99.6M 39.04M 485M 38.6M 37.76M 1.67B 368M 10.93M 9.58M 8.86M 8.15M 15.37M 1.05B 15.62M 106M 41.52M 516M 41.06M 40.16M 1.78B
Net income 15M 446K 391K 361K 332K 627K 42.98M 637K 4.32M 1.69M 21.03M 1.67M 1.64M 72.45M 17M 505K 443K 409K 376K 710K 48.71M 722K 4.89M 1.92M 23.83M 1.9M 1.86M 82.11M
Net Debt - -
Logo Genesis Fertility Center
Genesis Fertility Center PCL is a Thailand-based company engaged in the healthcare sector, primarily providing fertility and reproductive healthcare services. The Company provides treatment and counseling services to infertile people, chromosome analysis by NGS technique services and provide investment services in other businesses, consulting and management services. The Company provides assisted reproductive technology services, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI) and Intrauterine Insemination (IUI). Its service offerings also include Frozen Embryo Transfer (FET), egg freezing services and Preimplantation Genetic Testing for Aneuploidy (PGT-A) using laboratory-based screening methods. The Company serves both domestic and international patients through its network of fertility clinics and healthcare facilities. The Company operates through its subsidiaries such as Genosomics Company Limited, GFC Fertility Group Company Limited, and others.
Employees
-